Delivery Order SPE2DR25D2104-SPE2DR26F3NPC
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Januvia 100 mg tablets (90-count) valued at $4,365.84. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The order is scheduled for completion by September 16, 2025, and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 29, 2025, for the supply of Januvia 100 mg tablets in a quantity of 1,000 units, with a contract value of $2,133.49. This is a firm fixed-price delivery order under a non-competitive set-aside agreement, with an ultimate completion date of September 30, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of Januvia 100 mg tablets (90-count units) at a fixed price of $2,113.32. This non-set-aside competitive award is scheduled for completion by November 5, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 20, 2025, for the supply of Januvia 50 mg tablets (90-count packages) with a contract value of $1,056.72. This is a firm fixed price delivery order with an ultimate completion date of October 21, 2025, and represents a non-set-aside competitive award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $2,717.61 delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Januvia 100 mg tablets (90-count units). This firm fixed-price contract, which is a child award under a larger indefinite delivery vehicle, represents a competitively awarded non-set-aside delivery order with an ultimate completion date of September 4, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency's Medical Supply Chain awarded a competitive delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of Januvia 100mg tablets (90-count units) under a firm fixed-price contract valued at $10,040.31. This non-set-aside delivery order is scheduled for completion by October 22, 2025, with performance at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and...
- The Defense Logistics Agency awarded a $5,078.66 delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Januvia 100 mg tablets (90-count units). This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 11, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is executed under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $15,034.57 delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Januvia 100 mg tablets (90-count units). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of July 30, 2025, and represents a child order under AmerisourceBergen's broader pharmaceutical supply agreements. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and...
- The Defense Logistics Agency awarded a delivery order valued at $1,118.08 to AmerisourceBergen Drug Corp for the supply of Januvia 100 mg tablets (90-count units). This competitively awarded, firm fixed-price delivery order was issued on April 23, 2025, with an ultimate completion date of April 24, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Januvia 100 mg tablets (90-count) with a ceiling value of $9,111.37. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026. The delivery order was...
- SPE2DR25D2104Indefinite Delivery Contract
- SPE2DR25D2104-SPE2DR26F3NPCDelivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order on November 6, 2025, for supply of Januvia 100 mg tablets (90 count) valued at $2,156.12 with a firm fixed price contract type. The delivery order is non-competitive, with a completion deadline of November 7, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive global pharmaceutical support vehicle running through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal healthcare vendor, serves as a prime supplier for military and veteran healthcare systems through the DLA Medical Supply Chain. The company's extensive portfolio includes brand-name and generic medications across multiple therapeutic domains, with this Januvia order supporting diabetes medication requirements for federal healthcare beneficiaries. The underlying IDC represents a flexible contract vehicle enabling AmerisourceBergen to supply pharmaceutical products, vaccines, medical devices, and specialized healthcare commodities to customers including the Defense Health Agency and U.S. Coast Guard, positioning the company as a key participant in federal pharmaceutical procurement operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.2k | 11/6/25 |